.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

First-Line Extensive-Stage SCLC: Examining the New Role of Combination Chemotherapy and Immunotherapy

EP. 1: Background of Small Cell Lung Cancer

December 11th 2020

EP. 2: Differentiating Small Cell Lung Cancer and Non-Small Cell Lung Cancer

December 11th 2020

EP. 3: Aggressive Nature of Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 4: Rationale for I/O therapy in Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 5: Advances in Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 6: Results from the IMpower133 Trial for Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 7: Results from the CASPIAN Trial for Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 8: First-Line Approach for Treating Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 9: Treatment After Progression on Front-Line Therapy in Extensive-Stage Small Cell Lung Cancer

December 11th 2020

EP. 10: Ongoing Research in Extensive-Stage Small Cell Lung Cancer

December 11th 2020